<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> (AF) is the most common <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The risk of <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> is important, and at that time, there is no definite treatment for AF </plain></SENT>
<SENT sid="2" pm="."><plain>Oral anticoagulation also represents a hemorrhagic risk factor </plain></SENT>
<SENT sid="3" pm="."><plain>Ninety percent of atrial <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> are located within the left atrial appendage </plain></SENT>
<SENT sid="4" pm="."><plain>The percutaneous closure of this left atrial appendage with a device has been shown to decrease <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> even after interruption of oral anticoagulation as compared to <z:chebi fb="8" ids="10033">warfarin</z:chebi> in a recent randomized study </plain></SENT>
<SENT sid="5" pm="."><plain>Recent data support this innovative technique as a reasonable alternative to long term anticoagulation in patients at high risk of <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
</text></document>